AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Publishing timestamp: 2024-02-20 10:17:37
Summary
AbbVie announces Robert Michael as new CEO, replacing Richard Gonzalez. The company is facing competition for its blockbuster drug Humira but is hopeful for growth with newer drugs Skyrizi and Rinvoq. Gonzalez will retire and become executive chairman. Michael has been with AbbVie for over a decade and has played a key role in recent deals.
Sentiment: NEUTRAL
Keywords: pharmaceuticals, business, biotech and pharmaceuticals, abbott laboratories, health care industry, breaking news, biotechnology, abbvie inc, business news,
Source: https://www.cnbc.com/2024/02/20/abbvie-taps-robert-michael-as-ceo-succeeding-richard-gonzalez.html